UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054354
Receipt number R000062004
Scientific Title Effects of fixed limb position during orthosis therapy on joint range of motion and muscle activity in thumb CM arthropathy
Date of disclosure of the study information 2024/05/09
Last modified on 2025/02/03 11:47:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of orthotic therapy on upper limb function in thumb arthropathy

Acronym

Research on the effects of orthotic therapy on orthopedic disorders

Scientific Title

Effects of fixed limb position during orthosis therapy on joint range of motion and muscle activity in thumb CM arthropathy

Scientific Title:Acronym

Verification of the intervention effect of fixed limb position during orthosis therapy on joint range of motion and muscle activity in patients with carpometacarpal(CMC) arthropathy:randomized controlled trial

Region

Japan


Condition

Condition

Thumb CM arthropathy

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to create two types of splints, one fixed in radial abduction and one fixed in palmar abduction, for patients with thumb CM arthropathy, and to clarify the effects of fixed limb position on joint range of motion and muscle activity. Clarifying the effects of different fixed limb positions on joint range of motion and muscle activity.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Range of motion(ROM) in preoperative and postoperative evaluations (automatic or passive range of motion of thumb radial abduction, ulnar adduction, palmar abduction, palmar adduction, metacarpophalangeal(MP) joint flexion/extension, interphalangeal(IP) joint flexion/extension) difference

Key secondary outcomes

Preoperatively and postoperatively
(a) Differences in muscle strength such as pinch strength (finger pads/flanks) and grip strength
(b) Differences in thumb opposition function based on kapandji score
(c) Difference in pain based on Visual Analogue Scale(VAS) (rest, exercise, and weight bearing)
(d) Comparison of functional evaluation of hand pathology using Michigan Hand Outcomes Questionnaire(MHQ)
(e) Differences in upper limb function based on Simple Test for Evaluating Hand Function(STEF) and modified STEF
(f) Comparison of muscle activity using surface electromyogram (integral value of thenar muscle)
(g) Comparison of muscle contraction during exercise using ultrasound examination (muscle thickness of thenar muscle)
(h)Mini Mental State Examination
(i)Purdue Pegboard Test


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

radial abduction group
During the 3-week postoperative immobilization period, the limb was immobilized using a splint for the first postoperative week, and the limb was placed in radial abduction position using a splint during the first postoperative week.

Interventions/Control_2

palmar abduction group
During the 3-week postoperative immobilization period, the limb was immobilized using a splint for the first postoperative week, and the limb was placed in palmar abduction position using a splint during the first postoperative week.

Interventions/Control_3

Conservative treatment group
Surgery is not performed, and treatment includes exercise and orthotic therapy.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(a) Patients who are at least 18 years of age (adult) at the time of enrollment and have no cognitive impairment that would preclude their consent to participate in the study.
(b) Female patients diagnosed with CM arthropathy of the thumb and scheduled for conservative treatment and surgery (plasty).

Key exclusion criteria

Patients with neurological symptoms such as complex regional pain syndrome, patients with a history of surgery on the thumb, and patients who have undergone procedures or surgery that may affect postoperative ROM such as joint fusion surgery.

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Keisuke
Middle name
Last name Irie

Organization

Kyoto University

Division name

Department of Clinical Cognitive Neuroscience, Department of Human Health Sciences, Graduate School of Medicine

Zip code

606-8507

Address

53 Shogoin-kawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3968

Email

irie.keisuke.8n@kyoto-u.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name
Last name Irie

Organization

Kyoto University

Division name

Department of Clinical Cognitive Neuroscience, Department of Human Health Sciences, Graduate School

Zip code

606-8507

Address

53 Shogoin-kawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3968

Homepage URL


Email

irie.keisuke.8n@kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School of Medicine/Faculty of Medicine and Faculty of Medicine Hospital Medical Ethics Committee

Address

53 Shogoin-kawahara-cho, Sakyo-ku, Kyoto 606-8507

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

十条武田リハビリテーション病院(京都府)


Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 03 Month 01 Day

Date of IRB

2024 Year 05 Month 10 Day

Anticipated trial start date

2024 Year 05 Month 11 Day

Last follow-up date

2026 Year 05 Month 01 Day

Date of closure to data entry

2026 Year 11 Month 30 Day

Date trial data considered complete

2026 Year 11 Month 30 Day

Date analysis concluded

2026 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2024 Year 05 Month 09 Day

Last modified on

2025 Year 02 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062004